ClinicalTrials.gg
SupplementBiological

Lactobacillus plantarum 299 clinical trials

studies test it
3
open now
0
in phase 3
1
first study started
2012

How each study uses lactobacillus plantarum 299 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lactobacillus plantarum 299
3
Lactobacillus plantarum 299v
2

Development codes

DSM 6595
1

Other names

Lactobacillus plantarum strain 299
1

Studies by the year they started

3 studies that test it; most in 2012 (2)

Studies that test lactobacillus plantarum 299, by start year
YearStudies
20122
20181

By phase

A phase 1/2 study counts in both.

Phase 3
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 0 · Other 3

Region Skane (2) · Children's Oncology Group (1)

Often tested with

Tested in the same studies.

Lactiplantibacillus plantarum 299V (1)

Studies

Open first, then newest update. How each study uses lactobacillus plantarum 299 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Codes

What other systems call lactobacillus plantarum 299 · ClinicalTrials.gg INT015272

  • UNII (FDA) 6H16YUE9W5LACTOBACILLUS PLANTARUM 299One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.